Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

Curr Neuropharmacol · 2015 · PMC4761636 · PMID 26467414

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

These findings, and the fact that first-degree relatives of patients showed a trend towards lower levels of n3-PUFAs, suggest that n3-PUFAs may play a role in the treatment of BD.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.